» Articles » PMID: 30804536

Accessing Analytes in Biofluids for Peripheral Biochemical Monitoring

Overview
Journal Nat Biotechnol
Specialty Biotechnology
Date 2019 Feb 27
PMID 30804536
Citations 158
Authors
Affiliations
Soon will be listed here.
Abstract

Peripheral biochemical monitoring involves the use of wearable devices for minimally invasive or noninvasive measurement of analytes in biofluids such as interstitial fluid, saliva, tears and sweat. The goal in most cases is to obtain measurements that serve as surrogates for circulating analyte concentrations in blood. Key technological developments to date include continuous glucose monitors, which use an indwelling sensor needle to measure glucose in interstitial fluid, and device-integrated sweat stimulation for continuous access to analytes in sweat. Further development of continuous sensing technologies through new electrochemical sensing modalities will be a major focus of future research. While there has been much investment in wearable technologies to sense analytes, less effort has been directed to understanding the physiology of biofluid secretion. Elucidating the underlying biology is crucial for accelerating technological progress, as the biofluid itself often presents the greatest challenge in terms of sample volumes, secretion rates, filtration, active analyte channels, variable pH and salinity, analyte breakdown and other confounding factors.

Citing Articles

Tandem metabolic reaction-based sensors unlock in vivo metabolomics.

Cheng X, Li Z, Zhu J, Wang J, Huang R, Yu L Proc Natl Acad Sci U S A. 2025; 122(9):e2425526122.

PMID: 40014569 PMC: 11892595. DOI: 10.1073/pnas.2425526122.


Deep Learning-Enhanced Portable Chemiluminescence Biosensor: 3D-Printed, Smartphone-Integrated Platform for Glucose Detection.

Singhal C, Kaushik V, Awasthi A, Zalke J, Palekar S, Rewatkar P Bioengineering (Basel). 2025; 12(2).

PMID: 40001639 PMC: 11851613. DOI: 10.3390/bioengineering12020119.


Mass spectrometry-based analysis of eccrine sweat supports predictive, preventive and personalised medicine in a cohort of breast cancer patients in Austria.

Bolliger M, Wasinger D, Brunmair J, Hagn G, Wolf M, Preindl K EPMA J. 2025; 16(1):165-182.

PMID: 39991101 PMC: 11842658. DOI: 10.1007/s13167-025-00396-6.


Sub-femtomolar drug monitoring via co-calibration mechanism with nanoconfined DNA probes.

Chen Y, Li X, Yue X, Yu W, Shi Y, He Z Nat Commun. 2025; 16(1):1863.

PMID: 39984441 PMC: 11845792. DOI: 10.1038/s41467-025-57112-1.


Printable molecule-selective core-shell nanoparticles for wearable and implantable sensing.

Wang M, Ye C, Yang Y, Mukasa D, Wang C, Xu C Nat Mater. 2025; .

PMID: 39900737 DOI: 10.1038/s41563-024-02096-4.


References
1.
Heikenfeld J, Jajack A, Rogers J, Gutruf P, Tian L, Pan T . Wearable sensors: modalities, challenges, and prospects. Lab Chip. 2017; 18(2):217-248. PMC: 5771841. DOI: 10.1039/c7lc00914c. View

2.
Engler R, Routh T, Lucisano J . Adoption Barriers for Continuous Glucose Monitoring and Their Potential Reduction With a Fully Implanted System: Results From Patient Preference Surveys. Clin Diabetes. 2018; 36(1):50-58. PMC: 5774999. DOI: 10.2337/cd17-0053. View

3.
Christiansen M, Klaff L, Brazg R, Chang A, Levy C, Lam D . A Prospective Multicenter Evaluation of the Accuracy of a Novel Implanted Continuous Glucose Sensor: PRECISE II. Diabetes Technol Ther. 2018; 20(3):197-206. PMC: 5867508. DOI: 10.1089/dia.2017.0142. View

4.
Farandos N, Yetisen A, Monteiro M, Lowe C, Yun S . Contact lens sensors in ocular diagnostics. Adv Healthc Mater. 2014; 4(6):792-810. DOI: 10.1002/adhm.201400504. View

5.
Anderson J, Van Itallie C . Physiology and function of the tight junction. Cold Spring Harb Perspect Biol. 2010; 1(2):a002584. PMC: 2742087. DOI: 10.1101/cshperspect.a002584. View